InvestorsHub Logo

hope4patients

05/01/18 10:02 PM

#171082 RE: sentiment_stocks #171080

Thank you for this.

xoma4578

05/01/18 10:16 PM

#171083 RE: sentiment_stocks #171080

Hi Senti -

Do you meant to say “April 2018” in your post below?

Recently, here in April 2017, he writes
Quote:
That leaves the desperate and the experimental. So far, the latter have proven very difficult to access. There is good stuff on the horizon (ranging from vaccines to liquid aspirin) but the red tape in this field is frustrating.

longfellow95

05/02/18 5:38 AM

#171097 RE: sentiment_stocks #171080

Curious that his tumor sample was sent to Memphis, when he appears to be in the UK. It may be that back then (Sept '17), Advent had not initiated tumor storage or vaccine manufacture.

I'm assuming this is another patient qualifying under UK Specials.
Which means that his neuro surgeon/oncologist must have referred him and recommended this as the treatment of choice.

UK consultants would only be doing this if they had prior knowledge of patients who had done well on the trial, I would suggest.